[1] Volkow ND, Fowler JS, Gatley SJ, et al.PET evaluation of the dopamine system of the human brain[J].J Nucl Med,1996, 37:1242~1256.
[2] Wagner HN, Burns HD, Dannals RF, et al.Imaging DA receptors in the human brain by PET[J].Science, 1983, 221:1264~1266.
[3] Ichise M,Ballinger JR.SPECT imaging of dopamine receptors[J].J Nucl Med, 1996, 37(10):1591~1595.
[4] Seibyl JP, Woods SW, Zoghbi SS, et al.Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM[J].J Nucl Med, 1992, 33:1964~1971.
[5] Farde L, Hall H, Pauli S, et al.Variability in D2-dopamine receptor density and affinity:A PET study with 11C raclopride in man[J].Synapse, 1995, 20:200~208.
[6] Wang RF, Loćh C and Maziere B.Determination of Unchanged [18F] DOPA in human and non-human primate plasma during PET studies:A new solid-phase extraction method comparable to radio-thin-layer chromatography analysis[J].J Chromatography B:Biomedic Applicat,1997, 69:265~270.
[7] Ginovart N,Lundin A,Farde L,et al.PET study of the pre-and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease[J].Brain,1997, 120:503~514.
[8] Ichise M,Kim YJ,Erami SS,et al.Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-β-CIT SPECT data[J].J Nucl Med,1999, 40:530~538.
[9] Booij J,Habraken BA,Bergmans P,et al.Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease[J].J Nucl Med, 1998, 39:1879~1884.
[10] Seibyl JP, Wallac E, Smith ED, et al.Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects[J].J Nucl Med, 1994, 35:764~770.
[11] Küikka JT, Tiihonen J, Bergström KA, et al.Imaging of serotonin and dopamine transpoders in the living human brain[J].Eur J Nucl Med, 1995, 22:346~350.
[12] Kung MP, Stevenson DA, Plossl K, et al.[99mTc] TRODAT-1:a novel technetium-99m complex as a dopamine transporter imaging agent[J].Eur J Nucl Med, 1997, 24:372~380.
[13] Seibyl JP, Marek K, Hoffer PB, et al.[I-123]β-CIT SPECT imaging demonstrates markedly decreased striatal monoamine transporters in idiopathic Parkinson's disease[J].J Nucl Med, 1995, 35:10P.
[14] Volkow ND, Ding YS, Fowleer JS, et al.[11C]-d-thero-methylphenidate:a new PET ligand for the dopamine transporter.Ⅱ.Study of in the huamn brain[J].J Nucl Med,1995, 36:2162~2168.